Welcome to our new product “Friday Takeaway”
This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to help raise awareness



Friday Takeaway from UK Small Caps
This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to help raise awareness
23rd May 2025
Alphabetically arranged
Share prices and market capitalisations taken from Alpha Terminal from the current price on the day of publication.
Top three shareholders are taken from the websites of the companies that we are writing about, unless there is a more up to date TR-1 notification RNS announcement.
Digging through these companies’ recent announcements, we may have unearthed hidden value.
DNM: Fair Chance
KRM: Managing Risk
RTC: Recruitment Drive
Dianomi 27.5p £8.26m (DNM.L)
Financial Calendar:
Year End December, Finals reported 19 May, Interim results to June expected before end September
Top Three Shareholders:
Scobie Dickinson Ward 16%, BGF Nominees Limited 14.9%, Raphael Queisser 12.1%
Key Investment Points:
Losses narrowing, Cash increased to £8.8m, Media Platform reboot
The recent finals to December 2o24 reported progress on transitioning the established platform into a comprehensive, full-spectrum, digital advertising platform. The Platform provides over 350 advertisers, including blue chip names such as Aberdeen, Invesco, Bank of America and Charles Schwab, with access to an international audience of around 500m readers per month through its partnerships with over 300 premium publishers, including blue chips such as Reuters, CNN Business and WSJ. It listed at 273p, raising a net £3.93m, in May 2021 and has not raised further funds since. The forecast increase of 8-10% in digital advertising spending in the US**** is expected to exceed $325bn in 2025 and financial services, the Group's main sector, is projected to spend $33.81bn. Dianomi’s current small share of this provides plenty of growth potential.
The original established Native advertising platform was based on contextual human-interest stories. Native targeted audiences on desktop and mobile websites, mobile, and tablet applications of premium publishers. Revenue for the FY December 2024 declined 7.3% to £28m, while gross profits margin increased to 26.1% from 24.7% giving a slightly reduced EBITDA loss of £0.3m from a loss in the prior period of £0.4m. A PBT of £0.3m was reported compared to a £1.8m loss in the prior period. There were no borrowings at the year end, net cash was £8.8m which had improved from £7.7m at the end of 2023 and the current ratio is a robust 2.2x.
The transition into a broader strategy will be supported by investments in people and services to widen campaign capabilities to deepen the monetisation. Specialists’ sales teams are being formed to cover high value sectors such as travel, automotive, technology, property, and luxury goods. This broadens the reach beyond the core business and finance sectors. Supporting these market verticals is the newly developed Dianomi Insights, a proprietary analytics tool that enables brands to benchmark their media presence against industry peers. Revenue growth for H1 2025 is expected to be lower than last year but the board is confident of significant growth from the new strategy.
Hybridan Comment: The market capitalisation is covered by assets (primarily cash) and seems overly pessimistic.
KRM 32.50p £11.73m (KRM.L)
Financial Calendar:
Year End December, Finals reported 19 May, Interim results to June expected before end September
Top Three Shareholders:
Trading Technologies International Inc. 24.7%, Kestrel Investment Partners 17.1%, Canaccord Genuity 10.3%
Key Investment Points:
High Value Niche, Approaching break-even, Entreprenial Team
The Global Risk Platform is focused on reducing the cost and complexity of risk management. The Platform provides applications to help address a firms' trading and corporate risk challenges to manage their entire enterprise risk profile. Regulatory pressure is driving firms to refine procedures and technology enables greater accuracy, efficiency, and compliance. The global market for risk management software is worth approximately £6bn per annum.
At the start of 2024, serial tech entrepreneur Dan Carter and Gerry Jones were appointed as CEO and Non-Executive Chairman respectively. A cost savings programme was initiated, and the recently reported FY December 2024 showed a marked improvement in financial and operational performance. Revenues increased by 28.3% to £6.8m of which the Annualised Recurring Revenue (ARR) is £6.6m, which is a 22.2% increase compared to the previous period. The restructuring and rationalisation initiatives have reportedly reduced costs by £1.2m. EBITDA profit is£1m compared to an EBITDA loss of £1.3m in the prior period, while the Losses before Tax decreased to £1.4m from Losses before Tax in the prior period of £4.9m. The gross cash at the Y/E was £1m, compared to £0.9m at the end of December 2023.
During the period, 12 new ARR contracts were signed, which included 6 new customers, and there are now 44 institutional customers. The first sales have been received after the launch of a risk management application and the combination with Limits Manager streamlines a client’s risk operations and enhances its audit capabilities. A market Surveillance software has been developed with an Application Programming Interface (API), enabling the building of new web-based and added AI functionality focussed on monitoring, and this will be launched in 2025. A strong start to 2025 is reported with the ARR increasing further to £7.4m. Its risk management technology and services are even more essential to clients in volatile times, and this momentum is creating significant opportunities for growth.
Hybridan Comment: The approaching uplift to earnings may accelerate the entrepreneurial development and the market capitalisation seems moderate for its specialist services.
RTC Group 97.5p £12.24m (RTC.L)
Financial Calendar:
Year End December, Finals reported 24 March, Interim results to June expected before end September
Top Three Shareholders:
Estate of WJC Douie (Former Director) 20.73%, GA Mason 9.39%, A M Pendlebury (Executive Chairman and Chief Executive) 5.55%
Key Investment Points:
Diversity policy, Consolidation Opportunities, Low P/E and 5.4% yield
The business was founded in 1963 and focuses on white and blue-collar recruitment, providing temporary and permanent labour to a broad range of industries and customers, in both domestic and international markets. In the UK, the Group’s Ganymede and ATA Recruitment brands offer a wide range of recruitment services. Ganymede provides a diverse range of people solutions to the rail, energy, construction, highways, and transportation sectors. ATA Recruitment provides high-quality technical recruitment solutions to the manufacturing, engineering, and technology sectors. The International division works with customers on delivering projects in a variety of sectors, including in some of the world’s most hostile locations.
The finals to December 2024 reported a 2% decline in revenue to £96.8m, with a PBT increasing marginally to £2.6m from £2.5m in the prior period. RTC reported a fully diluted EPS of 13.01p against 12.72p at the end of December 2023, giving we calculate a P/E of 7.1x. The dividend was increased to 5p from 4.5p, giving a 5.4% yield. There is a solid order book across rail maintenance and renewals, and smart meter roll out and upgrades, alongside other key infrastructure programmes, providing some clear visibility for 2025 revenues.
The Trading update for the first quarter of 2025 given at this week’s AGM reported a continuing positive trading and cash generating trajectory. The update was from the CEO and Executive Chairman, Andrew Pendlebury, who was appointed to both roles following the sudden death in 2023 of WJC Douie. There are concerns however that the increases to employer's NI contributions and minimum wage will reduce companies’ recruitment, which would impact all UK recruiters. There is a no long-term debt and the balance sheet continues to improve due to strong operating cash flows, with £2.2m of cash generated from operations in 2024. The current ratio is 1.6x (ratio of current assets to current liabilities) and would be considered conservative.
Hybridan Comment: An upturn in the recruitment cycle may stimulate corporate activity and the Group seems well positioned to capitalise on new and emerging organic growth and M&A opportunities.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.